Table 3.
Prognostic factor | Studies | Associations | Best-evidence synthesis |
---|---|---|---|
Patient variables | |||
No association | |||
Body mass index | Strong evidence for no association | ||
No, no No, no, no, negative, positive |
|||
Female | Moderate evidence for no association | ||
No, positive, no No, no, no, no, no |
|||
Lower educational level | Moderate evidence for no association | ||
1 low risk of bias cohort [16] 1 cohort [39] |
No No |
||
Western or White ethnicity | Moderate evidence for no association | ||
1 low risk of bias cohort [16] 1 cohort [39] |
No No |
||
Alcohol consumption | Limited evidence for no association | ||
1 low risk of bias cohort [16] | No | ||
Conflicting evidence | |||
Higher age at baseline | Conflicting evidence | ||
No, positive,no No, positive$, no, no, positive |
|||
Disease characteristics | |||
Faster or more progression | |||
Lower global assessment (self-reported) at baseline | Moderate evidence for faster or more progression | ||
1 low risk of bias cohort [37] |
Positive Positive, positive |
||
Previous use of NSAIDs | Limited evidence for more progression | ||
1 low risk of bias cohort [37] | Positive | ||
No association | |||
Longer duration of symptoms at baseline | Moderate evidence for no association | ||
1 low risk of bias cohort [37] 1 cohort [19] |
No No |
||
Having another disease (comorbidity) | Moderate evidence for no association | ||
1 low risk of bias cohort [16] 1 cohort [39] |
No No |
||
Morning stiffness | Moderate evidence for no association | ||
1 low risk of bias cohort [16] 1 cohort [51] |
No No |
||
Use of pain medication at baseline | Moderate evidence for no association | ||
1 low risk of bias cohort [16] 1 cohort [19] |
No No |
||
Presence of Heberden’s or Bouchard’s nodes | Moderate evidence for no association | ||
1 low risk of bias cohort [16] |
No No, no |
||
Previous intra-articular injection in the hip | Limited evidence for no association | ||
1 low risk of bias cohort [37] | No | ||
Conflicting evidence | |||
More limitations in physical function at baseline | Conflicting evidence | ||
Positive, positive, no No, no |
|||
More pain at baseline | Conflicting evidence | ||
Conflicted$$, positive, positive Positive, no, positive, no |
|||
Painful hip flexion (active or passive) | Conflicting evidence | ||
1 low risk of bias cohort [16] 1 cohort [51] |
Positive No |
||
Painful hip internal rotation (active or passive) | Conflicting evidence | ||
1 low risk of bias cohort [16] 1 cohort [51] |
Positive No |
||
Night pain at baseline | Conflicting evidence | ||
2 cohorts [50, 51] | Positive, no | ||
Limited range of motion of flexion of the hip | Conflicting evidence | ||
1 low risk of bias cohort [16] |
Positive Positive, no |
||
Limited range of motion of internal hip rotation | Conflicting evidence | ||
1 low risk of bias cohort [16] |
Positive Positive, no |
||
Limited range of motion of external hip rotation | Conflicting evidence | ||
2 cohorts [19, 51] | Positive, no | ||
Chemical or imaging markers | |||
Faster or more progression | |||
Higher K-L grade at baseline | Strong evidence for more or faster progression | ||
2 low risk of bias cohorts [34, 37] 1 cohorts [51] |
Positive, positive Positive |
||
Superior or superolateral migration of the femoral head | Strong evidence for more or faster progression | ||
2 low risk of bias cohorts [34, 47] 1 cohort [38] |
Positive, positive Positive |
||
Subchondral sclerosis | Strong evidence for more progression | ||
2 low risk of bias cohorts [16, 47] | Positive, positive | ||
Statistical shape modeling | Moderate evidence that certain modes of SSM can predict progression | ||
3 cohorts [11, 12, 12] | Positive, positive, positive | ||
Joint space narrowing at baseline | Moderate evidence for more or faster progression | ||
1 low risk of bias cohort [16] 1 cohort [67] |
Positive Positive |
||
No association | |||
Cam-type deformity (alpha angle > 60°) | Limited evidence for no association | ||
1 low risk of bias cohort [16] | No | ||
Conflicting evidence | |||
Erythrocyte sedimentation rate | Conflicting evidence | ||
1 low risk of bias cohort [16] 1 cohort [51] |
Positive No |
||
Atrophic bone response (no osteophytes present) | Conflicting evidence | ||
1 low risk of bias cohort [16] |
Positive Positive, no |
||
Decrease in joint space width at baseline | Conflicting evidence | ||
1 low risk of bias cohort [34] 1 cohort [51] |
Positive No |
||
Wiberg’s center edge angle (CEA) | Conflicting evidence | ||
1 low risk of bias cohort [16] 1 cohort [20] |
Negative No |
$Exception: age ≥ 82 years showed a negative association with progression, compared to age ≤ 62 years
$$Pain at baseline measured with NRS past week showed a statistically significant positive association with THR; pain at baseline measured with WOMAC pain showed no statistically significant association with THR